Rebound	rebound	O	O
hypertensive	hypertensive	O	S_disease
after	after	O	O
sodium	sodium	B_chemical	O
nitroprusside	nitroprusside	S_chemical	O
prevented	prevented	O	O
by	by	O	O
saralasin	saralasin	S_chemical	O
in	in	O	O
rats	rats	O	O
.	.	O	O

The	the	O	O
role	role	O	O
of	of	O	O
the	the	O	O
renin	renin	O	O
--	--	O	O
angiotensin	angiotensin	S_chemical	O
system	system	O	O
in	in	O	O
the	the	O	O
maintenance	maintenance	O	O
of	of	O	O
blood	blood	O	O
pressure	pressure	O	O
during	during	O	O
halothane	halothane	S_chemical	O
anesthesia	anesthesia	O	O
and	and	O	O
sodium	sodium	B_chemical	O
nitroprusside	nitroprusside	S_chemical	O
(SNP)-induced	(snp)-induced	O	O
hypotension	hypotension	O	S_disease
was	was	O	O
evaluated	evaluated	O	O
.	.	O	O

Control	control	O	O
rats	rats	O	O
received	received	O	O
halothane	halothane	S_chemical	O
anesthesia	anesthesia	O	O
(	(	O	O
1	1	O	O
MAC	mac	O	O
)	)	O	O
for	for	O	O
one	one	O	O
hour	hour	O	O
,	,	O	O
followed	followed	O	O
by	by	O	O
SNP	snp	S_chemical	O
infusion	infusion	O	O
,	,	O	O
40	40	O	O
microgram/kg/min	microgram/kg/min	O	O
,	,	O	O
for	for	O	O
30	30	O	O
min	min	O	O
,	,	O	O
followed	followed	O	O
by	by	O	O
a	a	O	O
30-min	30-min	O	O
recovery	recovery	O	O
period	period	O	O
.	.	O	O

A	a	O	O
second	second	O	O
group	group	O	O
of	of	O	O
rats	rats	O	O
was	was	O	O
treated	treated	O	O
identically	identically	O	O
and	and	O	O
,	,	O	O
in	in	O	O
addition	addition	O	O
,	,	O	O
received	received	O	O
an	an	O	O
infusion	infusion	O	O
of	of	O	O
saralasin	saralasin	S_chemical	O
(	(	O	O
a	a	O	O
competitive	competitive	O	O
inhibitor	inhibitor	O	O
of	of	O	O
angiotensin	angiotensin	B_chemical	O
II	ii	I_chemical	O
)	)	O	O
throughout	throughout	O	O
the	the	O	O
experimental	experimental	O	O
period	period	O	O
.	.	O	O

In	in	O	O
each	each	O	O
group	group	O	O
,	,	O	O
SNP	snp	S_chemical	O
infusion	infusion	O	O
resulted	resulted	O	O
in	in	O	O
an	an	O	O
initial	initial	O	O
decrease	decrease	O	O
in	in	O	O
blood	blood	O	O
pressure	pressure	O	O
from	from	O	O
86	86	O	O
torr	torr	O	O
and	and	O	O
83	83	O	O
torr	torr	O	O
,	,	O	O
respectively	respectively	O	O
,	,	O	O
to	to	O	O
48	48	O	O
torr	torr	O	O
.	.	O	O

During	during	O	O
the	the	O	O
SNP	snp	S_chemical	O
infusion	infusion	O	O
the	the	O	O
control	control	O	O
animals	animals	O	O
demonstrated	demonstrated	O	O
a	a	O	O
progressive	progressive	O	O
increase	increase	O	O
in	in	O	O
blood	blood	O	O
pressure	pressure	O	O
to	to	O	O
61	61	O	O
torr	torr	O	O
,	,	O	O
whereas	whereas	O	O
the	the	O	O
saralasin-treated	saralasin-treated	O	O
animals	animals	O	O
showed	showed	O	O
no	no	O	O
change	change	O	O
.	.	O	O

Following	following	O	O
discontinuation	discontinuation	O	O
of	of	O	O
SNP	snp	S_chemical	O
,	,	O	O
blood	blood	O	O
pressure	pressure	O	O
in	in	O	O
the	the	O	O
control	control	O	O
animals	animals	O	O
rebounded	rebounded	O	O
to	to	O	O
94	94	O	O
torr	torr	O	O
,	,	O	O
as	as	O	O
compared	compared	O	O
with	with	O	O
78	78	O	O
torr	torr	O	O
in	in	O	O
the	the	O	O
saralasin-treated	saralasin-treated	O	O
rats	rats	O	O
.	.	O	O

This	this	O	O
study	study	O	O
indicates	indicates	O	O
that	that	O	O
with	with	O	O
stable	stable	O	O
halothane	halothane	S_chemical	O
anesthesia	anesthesia	O	O
,	,	O	O
the	the	O	O
partial	partial	O	O
recovery	recovery	O	O
of	of	O	O
blood	blood	O	O
pressure	pressure	O	O
during	during	O	O
SNP	snp	S_chemical	O
infusion	infusion	O	O
and	and	O	O
the	the	O	O
post-SNP	post-snp	O	O
rebound	rebound	O	O
of	of	O	O
blood	blood	O	O
pressure	pressure	O	O
can	can	O	O
be	be	O	O
completely	completely	O	O
blocked	blocked	O	O
by	by	O	O
saralasin	saralasin	S_chemical	O
.	.	O	O

This	this	O	O
demonstrates	demonstrates	O	O
the	the	O	O
participation	participation	O	O
of	of	O	O
the	the	O	O
renin	renin	O	O
--	--	O	O
angiotensin	angiotensin	S_chemical	O
system	system	O	O
in	in	O	O
antagonizing	antagonizing	O	O
the	the	O	O
combined	combined	O	O
hypotensive	hypotensive	O	S_disease
effects	effects	O	O
of	of	O	O
halothane	halothane	S_chemical	O
and	and	O	O
SNP	snp	S_chemical	O
.	.	O	O

